Patient responses to oxygen therapy (PROT)

Not Applicable

Recruiting

• Conditions: Acute illness requiring oxygen therapy delivered by a ventilator; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12621001420831
• Lead Sponsor: Fisher & Paykel Healthcare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-21
• Last Update Posted: 3 October 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Indication of hypoxemia (saturation below target range) requiring supplemental oxygen
2. 16 years or older
3. Provision of signed and dated informed consent form
4. Stated willingness to comply with all study procedures and availability for the duration of the study

Exclusion Criteria

1. Pregnancy or lactation
2. Known allergic reactions to or contraindications to components of the study intervention
3. Involvement in another investigational study at the same time that may affect the results of this present study
4. Patients who are intubated

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients’ SpO2 responses to FiO2 changes. The SpO2 will be assessed with a pulse oximeter.[Monitored continuously within the 24 hour observational period. ]

Secondary Outcome Measures

Name	Time	Method
/A[N/A]